Legislative record
Prescription Drug Price Relief Act of 2025
Congress.gov resources retrieved Sep 5, 2026 · Source record updated Mar 24, 2026
A committee has recorded action, but the bill has not necessarily been reported or passed.
Method: Classify only explicit procedural terms in the captured Congress.gov action text, using the furthest documented stage and making no prediction about later action. Reviewed Sep 4, 2026.
Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Cosponsor selection rule: show the official count for every bill in the fixed five-bill collection because it is a reproducible completeness indicator. Individual cosponsor names are omitted; the count does not describe support outside formal cosponsorship or predict action.
The sponsor is linked only when the approved person profile and Congress.gov Bioguide ID match.
Senate, Vermont
Subjects are Congress.gov indexing terms, not Gov Influence claims about policy merit, position, or effect.
Congress.gov supplied no legislative-subject rows in the captured subjects response. This does not mean the bill has no subject matter.
From the complete captured Congress.gov action list, select introduction, the first referral, committee, report, presidential, and enactment action when present, up to two chamber-passage actions, and the latest action; sort by date and remove exact duplicates.
Bill introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This is a selected procedural chronology, not every vote, amendment, motion, communication, or administrative action. Use the official all-actions link for the complete captured category.
Rows reproduce the captured Congress.gov committee resource. “None listed” describes this response, not all possible committee activity.
| Chamber | Committee | Type | Subcommittees listed |
|---|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Standing | None listed in captured referral record |
Reviewed classification based on the official Health policy area and bill title; it does not state a position on the bill.
Organization context appears only under an existing approved record basis. It does not state that lobbying targeted, supported, opposed, changed, or caused action on the bill.
No organization context has an approved record basis for this bill. Context is not added merely to make the five pages look symmetrical.
Interpretation
Continue exploring
issue
This page groups reviewed filings reported under Health Issues, Pharmacy, and Medicare/Medicaid codes. It shows disclosed activity without assigning support, opposition, motive, or policy impact.
person
Bernie Sanders represents Vermont in the U.S. Senate. This profile pairs his current official identity and health committee responsibility with selected sponsored prescription-drug legislation without policy evaluation.